{"top_spans": [[0, 0], [0, 1], [2, 2], [16, 17], [19, 19], [20, 27], [20, 29], [23, 27], [23, 29], [31, 31], [32, 32], [32, 38], [33, 33], [40, 41], [42, 42], [53, 53], [53, 55], [53, 58], [55, 55], [56, 56], [60, 60], [61, 61], [61, 66], [61, 67], [62, 62], [66, 66], [67, 67], [69, 69], [75, 78], [76, 78], [78, 78], [79, 79], [79, 81], [79, 85], [79, 87], [87, 87], [87, 89], [87, 92], [88, 92], [93, 93], [94, 94], [94, 97], [94, 100], [102, 102], [103, 111], [110, 110], [110, 111], [116, 119]], "predicted_antecedents": [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1], "document": ["krystal", "biotech", "announces", "positive", "interim", "results", "from", "placebo", "-", "controlled", "phase", "1", "2", "clinical", "trial", "of", "kb103", "kb103", "is", "krystal", "first", "off", "-", "the", "-", "shelf", "topical", "gene", "therapy", "candidate", "to", "treat", "patients", "suffering", "from", "dystrophic", "epidermolysis", "bullosa", "results", "on", "2", "patients", "met", "all", "primary", "efficacy", "presence", "of", "functional", "col7", "expression", "observation", "of", "nc1", "and", "nc2", "reactive", "anchoring", "fibrils", "and", "continued", "expression", "following", "repeat", "administration", "and", "safety", "endpoints", "no", "adverse", "events", "inflammation", "or", "irritation", "in", "topically", "administered", "kb103", "wounds", "krystal", "biotech", "pittsburgh", "stanford", "university", "principal", "investigator", "dermatological", "diseases", "bmz", "securities", "and", "exchange", "commission", "fda", "krystal", "biotech", "inc", "dystrophic", "epidermolysis", "bullosa", "epidermolysis", "bullosa", "us", "securities", "and", "exchange", "commission", "associate", "professor", "of", "dermatology", "dr", "peter", "marinkovich", "mechanism", "of", "action", "krystal", "clinical", "trial"], "clusters": []}